Edward Kammerer

Pharma Frantically Searching Humanity’s Medicine Cabinet For Non-Opioid Pain Medicines

As opioid addiction continues to ravage large swaths of the country, doctors are being urged to prescribe fewer narcotic painkillers, putting pressure on drug companies to come up with new ways to treat pain patients. [More]

(Charles Williams)

Drugs Approved Due To Fraudulent Research Still On Market, FDA Shrugs

The lower prices that come from competition when drug patents expire and generic versions hit the market is great for consumers, but do you know what’s terrible for consumers? Drugs that don’t work. Yet there may be drugs on your shelf at home right now that haven’t been proven safe, effective, and––in the case of generics–– equivalent to the original brand-name drug. The alleged poor practices by six chemists at one research company in Texas affected more than one hundred drugs on the market in the United States and Europe.


Rubber And Steel Fragments Found Inside Medication

Rubber And Steel Fragments Found Inside Medication

The FDA has sent a warning to biotech company Genzyme after particles of rubber, steel, and fibers were found in vials of five of their injectable medications. The contamination occurred during the manufacturing process, and the FDA is concerned because doctors could be, y’know, injecting garbage fragments into their patients.

Doctors Say Too Many Patients Can't Name The Drugs They Take

Doctors Say Too Many Patients Can't Name The Drugs They Take

Too many patients don’t remember the names of the medications they’re on, posing problems for doctors who are trying to treat them, warn researchers at Northwestern University’s Feinberg School of Medicine in Chicago. About 40% of the patients surveyed “could not accurately recall what drugs they were taking,” and among those with “low health literacy,” the rate jumped to 60%.